The primary input to deciding on the merit of proposals submitted to the NIH for potential funding, as most of my remaining blog audience well knows, is the outcome of the initial peer-review proce…| DrugMonkey
Mike Lauer, prior head of the Office of Extramural Research at the NIH, has been quoted in a recent Nature news bit by Max Kozlov on the Fiscal Year 2025 grant funding picture. Kozlov writes, in part, about the way that Multi-Year Funding has decreased the number of new grant awards, thereby letting success rates […]| DrugMonkey
Chatter on the socials today indicates that the NIH’s Director of the Center for Scientific Review is stepping down. [UPDATE 08/08/2025: NIH Director statement on Byrnes’ retirement.] N…| DrugMonkey
NIH has issued NOT-OD-25-132 Supporting Fairness and Originality in NIH Research Applications which informs us that NIH will only accept six new, renewal, resubmission, or revision applications fro…| DrugMonkey
